Website & contact details
- Group website
- The site of this company’s group or brand.
Alimera Sciences Limited
- Incorporated
- 3 April 2012 (14 years)
- Industry
- Other business support service activities n.e.c. (82990)
- Directors
- Stephen Philip CareyNikhil LalwaniPhilip John Ashman
- Owned by
- Ani Pharmaceuticals, Inc.
- Accounts type
- Full
- Region
- South East
- Address
- Form 1Bartley Wood Business ParkHookRG27 9XA
Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 17 April 2027
- Last conf. stmt
- 3 April 2026
Charges
- Total
- 3
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 3
Officers 4 active
Officer details are public data from the Companies House register.
Corporate Secretary · Appointed 30 January 2026
Carey, Stephen Philip
Director · Appointed 12 December 2024
American
Born April 1970 (56)
Lalwani, Nikhil
Director · Appointed 12 December 2024
Indian
Born July 1977 (49)
Ashman, Philip John
Director · Appointed 1 January 2013
British
Born February 1965 (61)
Officer history (10 former)
30 January 2026
30 January 2026
12 December 2024
Appointed Carey, Stephen Philip as Director
12 December 2024
Appointed Lalwani, Nikhil as Director
21 June 2024
Resigned Maltz, Elliot Jay as Director
21 June 2024
Resigned Eiswirth Jr, Richard S. as Director
1 January 2024
Resigned Skibsted, Russell as Director
1 January 2024
Appointed Maltz, Elliot Jay as Director
1 November 2023
1 November 2023
1 February 2023
Appointed Skibsted, Russell as Director
28 November 2022
Resigned Jones, John Philip as Director
28 July 2020
Appointed Jones, John Philip as Director
1 January 2019
Resigned Myers Jr, Charles Daniel as Director
1 January 2013
Appointed Ashman, Philip John as Director
4 April 2012
Appointed Myers Jr, Charles Daniel as Director
4 April 2012
4 April 2012
4 April 2012
4 April 2012
Appointed Eiswirth Jr, Richard S. as Director
3 April 2012
3 April 2012
3 April 2012
3 April 2012
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Ani Pharmaceuticals, Inc.
Corporate entity · Notified 16 September 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporate
Reg. no. 3379943
Former controllers (1)
16 September 2024
Ceased Alimera Sciences, Inc. — Owns 75–100% of shares
Financials
Balance sheet as at 31 December 2024 · full accounts
- Net Assets
- (£34,680,918)
- Cash
- £1,184,741
- Turnover
- £18,606,618
- Profit Before Tax
- (£15,183,160)
- Employees
- 29
- Debt Ratio
- 164%
- Current Ratio
- 1.7x
- Profit Margin
- -82%
Balance sheet detail
| 2024 | |
|---|---|
| Fixed Assets | £36,698,202 |
| Current Assets | £17,647,385 |
| Cash | £1,184,741 |
| Creditors (< 1 year) | £10,632,041 |
| Creditors (> 1 year) | £78,394,464 |
| Net Current Assets | £7,015,344 |
| Net Assets | (£34,680,918) |
| Shareholder Funds | (£34,680,918) |
| Turnover | £18,606,618 |
| Cost of Sales | £1,292,534 |
| Gross Profit | £17,314,084 |
| Admin Expenses | £27,249,313 |
| Operating Profit | (£9,935,229) |
| Profit Before Tax | (£15,183,160) |
| Tax | (£51,458) |
| Profit for Period | (£15,131,702) |
Filings 83
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 8 August 2026 | Compulsory strike-off action has been discontinued | |||
| 5 August 2026 | Confirmation statement with no updates | 3 April 2026 | ||
| 28 July 2026 | First Gazette notice for compulsory strike-off | |||
| 20 May 2026 | Director's details changed | |||
| 27 March 2026 | Full accounts | 31 December 2024 |
Other companies in this industry
Beaconsfield
Newcastle Upon Tyne
London
Kettering
London
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →